"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ"

A prospective, open-label, uncontrolled, non-randomized, single-center Phase I/II clinical trial evaluating the safety of Anakinra in the immediate post-transplant period following pancreatic transplantation

NCT Number	NCT07503834
Lead Sponsor	Nantes University Hospital
Conditions	Pancreatic Transplant
Enrollment	15 participants
Start Date	2026-05-01
Primary Completion	2028-11-01 (estimated)
Study Completion	2029-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-31